ClinicalTrials.Veeva

Menu

Development and Validation of a New Digital Dermatoscope in the United States

B

Barco

Status

Completed

Conditions

Skin Cancer

Treatments

Device: Digital dermoscopy

Study type

Observational

Funder types

Industry

Identifiers

NCT04047316
CI-PROT-0029

Details and patient eligibility

About

A completely new type of digital dermatoscope has been developed in order to take a significant step forward in technology for skin cancer imaging. By means of this study a better insight can be gained of the current performance and workflow in clinical dermatoscopy. This knowledge will be used to further improve the developed technology.

Enrollment

60 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 18 years or above.
  • Male or Female, aged less than 18 years, with informed consent of their legally authorized representative.
  • Patient presenting with any visible skin lesion for dermatologist review on a body site amenable to optimal photographic imaging.
  • Able and willing to comply with all study requirements.
  • Patient with a skin lesion that is clinically diagnosed by a dermatologist as benign, malignant or a suspicious skin lesion requiring excisional biopsy for histological diagnosis.

Exclusion criteria

  • Patients aged under 18 years old where the legally authorized representative is unable or unwilling to provide their informed consent.
  • Patients unable to provide informed consent.
  • Skin lesions in an anatomical site which is not suitable for photography including hair-obscured site, subungual lesion or inaccessible mucosal site.
  • Lesion is at a site where previous surgery was undertaken.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems